A few simple facts to get you started with the Copay Assistance Program

Who is eligible to save?*

If you've been prescribed REGRANEX (becaplermin) gel, 0.01% and pay more than $25 out of pocket for your prescription, whether you're insured or not, you may be eligible to save. Participants in governmental healthcare programs or where copay assistance is taxed, restricted, or otherwise prohibited by law are not eligible.

Just how much will I save?

Eligible recipients will pay the first $25; Smith & Nephew will pay the remaining out-of-pocket cost up to the next $200.* The card can be used for 2 prescription fills, up to a $400 maximum each year.

How does it work?*

Click the print card button to start printing your Copay Assistance Program card. Then, just give the printed card to your pharmacist, along with your insurance card (if you have one) and a valid prescription for REGRANEX gel. The amount you receive from the program will be subtracted from what you pay your pharmacy.

*Subject to the Copay Assistance Program Card Terms and Conditions below and on the back of the card.

Please be sure to read the "What is REGRANEX gel?" and "Important Safety Information" sections below, as well as the patient Medication Guide at the end of the REGRANEX gel Prescribing Information.

For more information about REGRANEX gel, please review the patient Medication Guide and talk with your healthcare provider.

Copay Assistance Program Terms and Conditions

Not valid for prescriptions eligible to be reimbursed under Medicare (including Medicare part D and Medicare Advantage), Medicaid, TRICARE, CHAMPUS, the Puerto Rico Governmental Health Insurance Plan, or other federal, state, or governmental healthcare programs. Valid in the U.S. only, void where taxed, restricted, or prohibited by law. Accepted by participating pharmacies only. This Copay Assistance Program is not insurance and may be changed or discontinued at any time without notice.

What is REGRANEX gel?

REGRANEX is a protein medicine made in yeast that is used with other ulcer care practices (such as good wound care) to treat diabetic sores (ulcers) of your legs or feet that are deeper than just your skin, in people who have good blood supply to the legs.

It is not known if REGRANEX is effective for the treatment of pressure ulcers or ulcers that are due to poor blood flow (circulation). It is not known if REGRANEX is safe and effective in children under 16 years of age.


REGRANEX gel is indicated for the treatment of lower extremity diabetic neuropathic ulcers that extend into the subcutaneous tissue or beyond and have an adequate blood supply when used as an adjunct to, and not a substitute for, good ulcer care practices.

  • The efficacy of REGRANEX gel has not been established for the treatment of pressure ulcers and venous stasis ulcers.
  • The effects of REGRANEX gel on exposed joints , tendons, ligaments, and bone have not been established in humans.
  • REGRANEX gel is a non-sterile, low bioburden preserved product. Therefore, it should not be used in wounds that close by primary intention.

Malignancies distant from the site of application have been reported in both a clinical study and in postmarketing use. The benefits and risks of REGRANEX gel treatment should be carefully evaluated before prescribing in patients with known malignancy.


©2018 Smith & Nephew, Inc. All rights reserved.
♢Trademark of Smith & Nephew, Inc.
All trademarks acknowledged.

This website is intended for individuals age 18 and over in the United States only. The information provided is for information purposes only and is not intended to be medical advice. It does not replace the professional training, experience , and knowledge of the healthcare provider responsible for patient care, who must base treatment upon the unique characteristics of each patient.

If you have questions about REGRANEX (becaplermin) gel, 0.01%, that are not answered by this website ; contact your healthcare provider.


{"crx-wl-channel":"web","crx-wl-survey-description":"Agreement Certification","crx-wl-survey-name":"Regranex Patient Survey v1.0.0","groupNumber":"EC92001002","client":"asembia","brand":"regranex","brandPath":"regranex","view":"home"}